Literature DB >> 12745891

Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries.

Donald G Stein1, Stuart W Hoffman.   

Abstract

Estrogen and progesterone are often thought of as steroid hormones that strongly influence reproductive and maternal behaviours. However, the steroids are now showing considerable promise as neuroprotective and neuroregenerative agents in stroke and traumatic brain injuries. Collectively, these two hormones have been reported to reduce the consequences of the injury cascade by enhancing anti-oxidant mechanisms, reducing excitotoxicity: altering glutamate receptor activity, reducing immune inflammation, providing neurotrophic support, stimulating axonal remyelinization and enhancing synaptogenesis and dendritic arborization. Estrogen has often been tried as a prophylactic treatment in females for ischemic brain injury, while progesterone has, thus far, been given as a post-injury treatment for both male and female subjects with acute, ischemic and traumatic injuries of the brain and spinal cord. This review compares and evaluates estrogen and progesterone as neuroactive agents in the acute treatment of brain damage caused by stroke and trauma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12745891     DOI: 10.1080/1363849031000095279

Source DB:  PubMed          Journal:  Pediatr Rehabil        ISSN: 1363-8491


  38 in total

1.  Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.

Authors:  Jessica M Crain; Jyoti J Watters
Journal:  Open Drug Discov J       Date:  2010-01-01

2.  Hormonal modulators of glial ABCA1 and apoE levels.

Authors:  Jianjia Fan; Yoko Shimizu; Jeniffer Chan; Anna Wilkinson; Ayaka Ito; Peter Tontonoz; Edie Dullaghan; Liisa A M Galea; Tom Pfeifer; Cheryl L Wellington
Journal:  J Lipid Res       Date:  2013-09-02       Impact factor: 5.922

Review 3.  Functional neuroimaging studies of cognitive recovery after acquired brain damage in adults.

Authors:  Juan M Muñoz-Cespedes; Marcos Rios-Lago; Nuria Paul; Fernando Maestu
Journal:  Neuropsychol Rev       Date:  2005-12       Impact factor: 7.444

4.  Salutary Effects of Estrogen Sulfate for Traumatic Brain Injury.

Authors:  Hyunki Kim; Betul Cam-Etoz; Guihua Zhai; William J Hubbard; Kurt R Zinn; Irshad H Chaudry
Journal:  J Neurotrauma       Date:  2015-04-22       Impact factor: 5.269

5.  Impact of continuous versus discontinuous progesterone on estradiol regulation of neuron viability and sprouting after entorhinal cortex lesion in female rats.

Authors:  Anna M Barron; Meghan A Brown; Todd E Morgan; Christian J Pike
Journal:  Endocrinology       Date:  2014-12-16       Impact factor: 4.736

6.  Progesterone protects mitochondrial function in a rat model of pediatric traumatic brain injury.

Authors:  Courtney L Robertson; Manda Saraswati
Journal:  J Bioenerg Biomembr       Date:  2014-10-28       Impact factor: 2.945

Review 7.  Progesterone and vitamin d hormone as a biologic treatment of traumatic brain injury in the aged.

Authors:  Donald G Stein; Milos M Cekic
Journal:  PM R       Date:  2011-06       Impact factor: 2.298

8.  Biomechanics of head impacts associated with diagnosed concussion in female collegiate ice hockey players.

Authors:  Bethany J Wilcox; Jonathan G Beckwith; Richard M Greenwald; Neha P Raukar; Jeffrey J Chu; Thomas W McAllister; Laura A Flashman; Arthur C Maerlender; Ann-Christine Duhaime; Joseph J Crisco
Journal:  J Biomech       Date:  2015-04-15       Impact factor: 2.712

9.  Soluble epoxide hydrolase: regulation by estrogen and role in the inflammatory response to cerebral ischemia.

Authors:  Ines P Koerner; Wenri Zhang; Jian Cheng; Susan Parker; Patricia D Hurn; Nabil J Alkayed
Journal:  Front Biosci       Date:  2008-01-01

10.  Sex differences in outcome after mild traumatic brain injury.

Authors:  Jeffrey J Bazarian; Brian Blyth; Sohug Mookerjee; Hua He; Michael P McDermott
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.